Find your next paid study

Intervene Immune, Inc.NCT04375657

~$75 – $2,800

Actual pay is set by the research site.

Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy

Readmission rates for patients with hepatic encephalopathy due to end stage liver disease are high. Hyperammonemia contributes significantly to encephalopathy …

Hepatic Encephalopathy

The Cleveland ClinicNCT04096014

~$10 – $750

Actual pay is set by the research site.

Stroke, AcuteStrokeStroke, Cardiovascular+2 more

Efficacy of an Evidence-based Telehealth-delivered Weight-loss Intervention to Enhance Access and Reach Underserved Groups After Stroke

Investigators will conduct a randomized controlled trial (RCT) to assess intervention efficacy of telehealth delivery of the GLB-CVA (tGLB-CVA) compared to a 6…

Baylor Research InstituteNCT06569121

Actual pay is set by the research site.

Natural History of Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment

Background: In Fontan Associated Liver Disease (FALD), congestion of blood in the liver causes cirrhosis. This condition can cause death. Researchers want to …

Congenital Heart Disease

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT05213598

~$10 – $675

Actual pay is set by the research site.

Treatment for Opioid Use Disorder

A Study to Train a Machine Learning Algorithm for an Evaluation of the Use of Biometric Data Captured at the Wrist for the Identification of Acute Opioid Use Events and the Quantification of Opioid Withdrawal in Opioid Dependent Individuals

To train a machine learning model/algorithm for an evaluation of the use of biometric data captured at the wrist for the identification of acute opioid use eve…

Actual pay is set by the research site.

OpiAIDNCT07405398

Losing Specificity: the Role of the Locus Coeruleus in Age-related Distractibility

A growing body of research has highlighted the importance of frontal regions, at both the functional and structural levels, in age-related declines in attentio…

AgingAlzheimer Disease

Virginia Polytechnic Institute and State UniversityNCT05574634

~$10 – $750

Actual pay is set by the research site.

Prospective Evaluation of Emgality (Galcanezumab) in Breastmilk in Adult Women With Migraine

The goal of this project is to evaluate galcanezumab transfer into maternal breastmilk, and to evaluate infant (growth, development, constipation, colic, infec…

Migraine

University of California, San FranciscoNCT06085144

~$10 – $675

Actual pay is set by the research site.

Prospective Evaluation of Hypoxia in Primary Melanoma

When controlling for tumor present in the Sentinel lymph node (SLN), intranodal hypoxia, as measured by Carbonic Anhydrase IX (CAIX IHC), is associated with wo…

Melanoma

Actual pay is set by the research site.

Yana NajjarNCT06831071

Phase 2

Testing Heart Failure Resilience Intervention for Caregivers (HEROIC) in Advanced Heart Failure

This study will test the mechanisms of a multi-component, nurse-led, primary palliative care intervention, HEart failure Resilience Intervention for Caregivers…

Heart FailureCaregiver

Johns Hopkins UniversityNCT07805811

~$75 – $2,000

Actual pay is set by the research site.

Phase 3

DESTINY-Endometrial01: An Open-Label, Sponsor-Blinded, Randomized, Controlled, Multicenter, Phase III Study of Trastuzumab Deruxtecan (T-DXd) Plus Rilvegostomig or Pembrolizumab vs Chemotherapy Plus Pembrolizumab as First-Line Therapy of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR), Primary Advanced or Recurrent Endometrial Cancer

DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + rilvegostomig (Arm A) and/or T-DXd+ pembrolizumab (Arm B) when compared to chemothera…

Endometrial Cancer

~$50 – $2,250

Actual pay is set by the research site.

AstraZenecaNCT06989112

Phase 2

Randomized Phase II Trial Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma

This is a Phase 2 clinical trial with a 2:1 randomization comparing neoadjuvant Nivolumab + Relatlimab (Opdualag) vs neoadjuvant Nivolumab in patients with res…

Basal Cell Carcinoma

University of California, San DiegoNCT06624475

~$75 – $2,000

Actual pay is set by the research site.

Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer

To goal of this clinical trial is to quantify the dose-response effects of aerobic exercise training compared to attention control on chemotherapy relative dos…

Colonic Neoplasms